Epidemic model of HIV infection and AIDS in Argentina. Status in 1990 and predictive estimates. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Epidemic model of HIV infection and AIDS in Argentina. Status in 1990 and predictive estimates.

Medicina (B Aires). 1992;52(3):225-35. Unique Identifier : AIDSLINE MED/94111648
Raggi R; Blanco GA; Catedra de Patologia II, Facultad de Ciencias Medicas,; Universidad Nacional de La Plata, Argentina.


Abstract: The purpose of this paper was to evaluate the prevalence of HIV infection and AIDS in Argentina, to study the dynamics of the spread of HIV and to predict the future course by means of an epidemic model. The model was constructed using differential equations to describe the interactions between members of the various groups at risk. The functional form of the solutions was used in a back calculation procedure using data from cohort studies which were done in other countries (U.S.A. and France) together with data of AIDS cases reported to the National AIDS Program, to determine the time evolution of HIV-infection in each of the groups at risk defined. Results show that HIV was introduced in Argentina during the early 80's and affected persons of the homosexual/bisexual group in a first stage. In April 1990 it was estimated that there were a total of 34,131 HIV-infected persons. Intravenous drug users (IVDU) represented 39.5%, homosexual/bisexual men 47.6% and heterosexual adults 11%. It is estimated that in December 1992 there will be 107,946 HIV-infected persons where heterosexuals contribute with more than 20% of that value. AIDS cases predicted for the same period are 4130, with 1958 among homosexual/bisexual, 1483 among IVDU, 449 in heterosexual adults, 153 in children under 4 years old and 87 among hemophiliacs or patients with blood coagulation disorders. By the end of 1994 the model predicts more than 200,000 HIV infected persons with an important proportion of heterosexual adults and more than 12,000 AIDS cases. The values of this period must be considered as a future possible scenario if the present spread conditions are preserved. Infection among heterosexual adults is at the present time in a first and exponential phase of spread and dominated by transmission from IVDU group and bisexual men. It is concluded that the future course of AIDS epidemic in Argentina may be particularly influenced by changes in the heterosexual behavior particularly in those with a higher degree of exposure to HIV-infection.
Keywords: Acquired Immunodeficiency Syndrome/*EPIDEMIOLOGY Adult Argentina/EPIDEMIOLOGY Blood Coagulation Disorders/EPIDEMIOLOGY Blood Transfusion/ADVERSE EFFECTS Child, Preschool Cohort Studies Comorbidity *Disease Outbreaks Female Health Planning Hemophilia/EPIDEMIOLOGY Human HIV Infections/*EPIDEMIOLOGY/TRANSMISSION HIV Seroprevalence Infant Infant, Newborn Male *Models, Theoretical Pregnancy Pregnancy Complications, Infectious/EPIDEMIOLOGY Risk Factors Sex Behavior/STATISTICS & NUMER DATA Substance Abuse, Intravenous/EPIDEMIOLOGY Time Factors JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/KWDepidemiologyadultargentina/epidemiologybloodcoagulationdisorders/epidemiologybloodtransfusion/adverseeffectschild,preschoolcohortstudiescomorbidityKWDdiseaseoutbreaksfemalehealthplanninghemophilia/epidemiologyhumanhivinfections/KWDepidemiology/transmissionhivseroprevalenceinfantinfant,newbornmaleKWDmodels,theoreticalpregnancypregnancycomplications,infectious/epidemiologyriskfactorssexbehavior/statistics&numerdatasubstanceabuse,intravenous/epidemiologytimefactorsjournalarticle
940430
M9440873

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .